Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Revolution Medicines, Inc. - Common Stock (NQ:RVMD)

31.73 -1.14 (-3.47%)
Streaming Delayed Price Updated: 12:16 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Revolution Medicines, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Nasdaq Turns Higher; Akumin Shares Jump
U.S. stocks pared losses midway through trading, with the Nasdaq Composite gaining over 60 points on Monday. The Dow traded down 0.01% to 33,126.50 while the NASDAQ rose 0.54% to 13,054.00. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Revolution Medicines Stock Is Crashing Today
Investors were disappointed by Revolution Medicines' data, presented at ESMO. 
Via The Motley Fool
FMC, Li-Cycle Holdings, Okta And Other Big Stocks Moving Lower On Monday
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Revolution Medicines Crashes 39% On Lackluster Test Results In Cancer Treatment
The results were "at best, in line" with expectations for lung and pancreatic cancer treatment. 
Via Investor's Business Daily
Dow Falls Over 100 Points; Chicago Fed National Activity Index Increases In September
U.S. stocks traded lower this morning, with the Dow Jones index falling over 100 points on Monday. Following the market opening Monday, The Dow traded down 0.41% to 32,991.58 while the NASDAQ fell... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Expert Ratings for Revolution Medicines
Via Benzinga
Stifel Maintains Buy Rating for Revolution Medicines: Here's What You Need To Know
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Revolution Medicines Stock Joins Elite Club With RS Ratings Over 90
Revolution Medicines shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. 
Via Investor's Business Daily
Lululemon, PCTEL, Consolidated Communications, Other Stocks Jumping Higher On Monday
U.S. stocks traded higher, with the Dow Jones gaining more than 350 points on Monday. Here are some stocks recording big gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Shares of Revolution Medicines Were Popping on Friday
The company released positive phase 1/1b trial data on two cancer therapies. 
Via The Motley Fool
Analyst Ratings for Revolution Medicines
Via Benzinga
Revolution Medicines Earnings Preview
Via Benzinga
Revolution Medicines Earnings Preview
Via Benzinga
Where Revolution Medicines Stands With Analysts
Via Benzinga
Why Is Cancer Focused Revolution Medicines Stock Trading Higher Today?
Revolution Medicines Inc (NASDAQ: RVMD) released preliminary data for RMC-6236, its RASMULTI(ON) Inhibitor, and RMC-6291, its RASG12C(ON) Inhibitor, from the  
Via Benzinga
Top 4 Health Care Stocks That Are Preparing To Pump This Quarter
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Capri Holdings Limited (NYSE – CPRI), Avid® (Nasdaq - AVID), EQRx, Inc. (Nasdaq - EQRX)
From Brodsky & Smith LLC
Via GlobeNewswire
Why Revolution Medicines Stock Is Trading Lower
Revolution Medicines Inc (NASDAQ: RVMD) shares are trading lower by 8.77% to $24.18 Thursday morning after the company announced a $300 million offering of common stock. 
Via Benzinga
Top 5 Health Care Stocks That May Crash In Q3
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Revolution Medicines To Acquire EQRx In All-Stock Transaction To Gain Over $1B In Additional Capital
Revolution Medicines Inc (NASDAQ: RVMD) has agreed to acquire EQRx Inc (NASDAQ: EQRX) in an all-stock transaction intended to add more than $1 billion in net cash to  
Via Benzinga
RVMD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Revolution Medicines, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional Capital
From Revolution Medicines, Inc.; EQRx, Inc.
Via GlobeNewswire
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
Where is the current bull market? All indications would be that it's in biotech! The broader market is not really moving. There have been plenty of attention-grabbing headlines, and earnings season is... 
Via Benzinga
$140M Bet On Southwest Gas? Check Out These 4 Stocks Insiders Are Buying
Although US stocks closed lower on Friday, there were a few notable insider trades. 
Via Benzinga
Why Revolution Medicines Shares Are Trading Higher Today
Revolution Medicines, Inc. (NASDAQ: RMVD) shares are trading higher after the company reported better-than-expected fourth-quarter results. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS